SREBF1 and infection: The 25-hydroxycholesterol (25HC), a cholesterol metabolite inhibiting activation of SREBP1, suppresses infection of a broad range of pathogenic viruses, including influenza virus (28), Zika (29), and SARS-CoV-2 (30, –32).